About My Health Careers Internship MedBlogs Contact us

New Treatment Benefits Patients With Rare Genetic Disorder

by Colleen Fleiss on September 3, 2020 at 3:11 AM
Font : A-A+

New Treatment Benefits Patients With Rare Genetic Disorder

In patients with a rare and aggressive form of leukodystrophy, a class of targeted therapy drugs could help improve their neurological function, revealed new findings published today in the New England Journal of Medicine.

Aicardi-Goutières syndrome (AGS) is a rare genetic disorder and type of leukodystrophy that affects the brain and immune system. In patients with AGS, the body's immune system turns on itself in a destructive way, targeting the brain's white matter, causing most children with the disorder to experience mild to severe intellectual or physical impairments. Most children with AGS are unable to walk or talk and have multisystemic complications, including skin inflammation.


Prior studies have linked the activation of interferons - signaling proteins that respond to various immune disruptions - to exacerbated symptoms in AGS. Researchers at CHOP wanted to explore whether a class of small molecule inhibitor drugs called janus kinase (JAK) inhibitors could be used to block interferon activation in a way that helped these patients.

"Because treatment options for AGS are limited and the symptoms that these patients experience are so severe, there is a need to explore a wide variety of options," said senior author Adeline Vanderver, MD, an attending physician in the Division of Neurology, Program Director of the Leukodystrophy Center, and Jacob A. Kamens Endowed Chair in Neurologic Disorders and Translational Neurotherapeutics at CHOP.

The study was conducted at CHOP with 35 international patients with genetically confirmed AGS. These patients received baricitinib, an oral JAK1 and JAK2 inhibitor, with doses based on each patient's renal function, age and symptoms. Patients had their developmental histories evaluated from the onset of the disease to the end of the study, which ranged from 7.4 months to 41.5 months. The study team analyzed a variety of developmental milestones, including head control, sitting, rolling, smiling, babbling, and the use of single words and word combinations.

Before the patients in this study received treatment, 26 of the 35 had stable or declining neurologic function, and 9 of the 35 patients gained one or two of these developmental skills after disease onset. However, during the study, 20 patients met new milestones, and 12 patients gained between two to seven new skills. The improvements were typically observed within three months into the study and persisted. Children who received higher doses of the therapy appeared to achieve more of these milestones.

Some of the AGS patients who received baricitinib were at risk for developing thrombocytosis, leukopenia, and infection and therefore should be monitored closely while taking the drug.

"Measuring neurologic improvements in these patients is a complex process, but the results of this study are encouraging, especially because we observed improvements even in patients with severe and long-standing disease," Vanderver said.

Source: Eurekalert

News A-Z
News Category
What's New on Medindia
Black Pepper as Preventive Measure Against Omicron
FODMAP Diet: A Beginner's Guide
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Amniocentesis Genetics and Stem Cells Down Syndrome Progeria Cystic Fibrosis Niemann-Pick Disease Weaver Syndrome Marfan Syndrome Gaucher’s Disease Aarskog - Scott syndrome 

Recommended Reading
Achondroplasia is a rare genetic disorder of bone growth that causes short-limbed dwarfism. It ......
New Insights into Cleidocranial Dysplasia (CCD), a Rare Disorder
Cleidocranial dysplasia (CCD) is a rare disorder of which the most prominent features are missing .....
Internet may be a Valuable Tool for People with Undiagnosed Rare Disorders
Internet can serve as a helpful pathway to diagnosis and care for people who suspect they have a ......
Antibodies in Patients With Rare Disorder may Prevent Type 1 Diabetes and Psoriasis
The antibodies were derived from people with a rare autoimmune disorder, called autoimmune ......
Aarskog - Scott syndrome
Aarskog syndrome is a genetic disorder that mainly affects males. It affects the development of many...
Cystic Fibrosis
Cystic fibrosis is a genetic disease involving the mucus and sweat glands and the medical world has ...
Down Syndrome
Down Syndrome is a congenital disorder among children commonly born to older mothers. The condition ...
Gaucher’s Disease
Gaucher’s disease is a rare genetic disorder. It belongs to a group of diseases called glycolipid st...
Marfan Syndrome
Marfan syndrome is a genetic disorder of the connective tissue, which affects multiple organ systems...
Niemann-Pick Disease
Niemann–Pick disease is a group of inherited metabolic disorders in which cholesterol and lipids acc...
‘Paa’ is a film in which Amitabh Bachchan, in a rare role reversal, plays son to Abhishek Bachchan, ...
Weaver Syndrome
Weaver syndrome is a genetic disorder in which children show accelerated bone growth, advanced bone ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use